Aurisco Pharmaceutical Co.,Ltd. (605116.SS)

CNY 20.8

(-0.48%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.57 Billion 2.03 Billion 1.72 Billion 1.53 Billion 1.1 Billion 920.69 Million
Total Current Assets 1.36 Billion 1.08 Billion 939.79 Million 977.75 Million 664.85 Million 553.75 Million
Cash And Short Term Investments 545.83 Million 391.74 Million 444.61 Million 564.09 Million 265.05 Million 180.71 Million
Cash and Cash Equivalents 545.83 Million 391.74 Million 444.61 Million 564.09 Million 265.05 Million 180.71 Million
Short Term Investments -6.9 Million - - - - 299.99 Thousand
Net Receivables 302.54 Million 236.57 Million 154.19 Million 152.8 Million 144.07 Million 129.34 Million
Inventory 509.79 Million 444.93 Million 326.79 Million 237.79 Million 240.2 Million 227.93 Million
Other Current Assets 7.85 Million 15.1 Million 14.19 Million 23.06 Million 15.52 Million 15.76 Million
Total Non-Current Assets 1.2 Billion 944.48 Million 781.63 Million 555.45 Million 435.39 Million 366.93 Million
Net PPE 878.32 Million 674.18 Million 593.26 Million 490.35 Million 382.72 Million 328.22 Million
Good Will And Intangible Assets 121.39 Million 122.71 Million 40.41 Million 41.93 Million 42.69 Million 32.71 Million
Good Will - - - - - -
Intangible Assets 121.39 Million 122.71 Million 40.41 Million 41.93 Million 42.69 Million 32.71 Million
Long-Term Investments 86.2 Million 55.3 Million 15.3 Million 299.99 Thousand 300 Thousand 1.00
Tax Assets 14.29 Million 12.78 Million 8.55 Million 6.3 Million 9.66 Million 5.7 Million
Other Non Current Assets 108.34 Million 79.5 Million 124.09 Million 16.56 Million 1.00 300 Thousand
Other Assets - 1.00 1.00 - 1.00 1.00
Total Liabilities 607.02 Million 348.68 Million 213.43 Million 147.98 Million 122.96 Million 133.15 Million
Total Current Liabilities 501.02 Million 322.17 Million 193.07 Million 141.61 Million 116.63 Million 129.57 Million
Account Payables 282.44 Million 149.88 Million 137.27 Million 97.04 Million 78.95 Million 95.11 Million
Tax Payables 19.86 Million 14.95 Million 10.57 Million 18.29 Million 17.42 Million 18.01 Million
Short Term Debt 45.18 Million 36.22 Million 4.06 Million 5.81 Million 6.76 Million 9.05 Million
Deferred Revenue 173.31 Million 977.08 Thousand 50.75 Million 1.92 Million 107.28 Thousand 40.88 Thousand
Other Current Liabilities 75.8 Thousand 135.08 Million 982.82 Thousand 36.81 Million 30.81 Million 25.35 Million
Total Non Current Liabilities 106 Million 26.51 Million 20.35 Million 6.37 Million 6.32 Million 3.58 Million
Long-Term Debt 71.69 Million 16.45 Million 13.9 Million 6.76 Million - -
Deferred Revenue Non Current 34.01 Million 7.69 Million 4.53 Million 4.13 Million 4.38 Million 3.01 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.00 1.00 1.00 -6.76 Million 1.00 1.00
Other Liabilities 0.00 - 1.00 - - -
Total Equity 1.96 Billion 1.68 Billion 1.5 Billion 1.38 Billion 977.28 Million 787.54 Million
Stock Holders Equity 1.96 Billion 1.67 Billion 1.5 Billion 1.38 Billion 977.28 Million 787.54 Million
Common Stock 406.19 Million 406.19 Million 401 Million 401 Million 360 Million 360 Million
Retained Earnings 881.69 Million 680.06 Million 537.87 Million 429.05 Million 321.47 Million 147.81 Million
Accumulated other comprehensive income 127.89 Million 105.23 Million 77.49 Million 65.3 Million 78.39 Million 279.72 Million
Common Stock Equity 1.96 Billion 1.67 Billion 1.5 Billion 1.38 Billion 977.28 Million 787.54 Million
Capital Lease Obligation 11.23 Million 12.23 Million 13.9 Million 6.76 Million - -
Total Investments 79.29 Million 55.3 Million 15.3 Million 300 Thousand 300 Thousand 300 Thousand
Total Debt 116.88 Million 52.68 Million 17.97 Million 12.58 Million 6.76 Million 9.05 Million
Net Debt -428.95 Million -339.05 Million -426.63 Million -551.5 Million -258.29 Million -171.65 Million

Balance Sheet Charts